Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Tierney David S | Director | Apr 08 '24 | Option Exercise | 4.01 | 25,000 | 100,250 | 373,874 | Apr 10 05:15 PM | Tierney David S | Director | Apr 08 '24 | Sale | 15.68 | 25,000 | 392,000 | 348,874 | Apr 10 05:15 PM | Elsbernd Brian | Chief Compliance/Legal Officer | Mar 27 '24 | Sale | 16.44 | 25,000 | 411,000 | 124,433 | Mar 28 04:45 PM | DENKHAUS DONALD A | Director | Feb 05 '24 | Option Exercise | 4.01 | 40,000 | 160,400 | 434,333 | Feb 06 05:00 PM | MCENANY PATRICK J | Chairman of Board of Directors | Jan 02 '24 | Option Exercise | 1.13 | 250,000 | 282,500 | 4,385,256 | Jan 03 05:19 PM | O'Keeffe Charles B | Director | Jan 02 '24 | Option Exercise | 1.13 | 60,000 | 67,800 | 681,724 | Jan 03 05:18 PM | Tierney David S | Director | Jan 02 '24 | Option Exercise | 1.13 | 10,000 | 11,300 | 344,874 | Jan 03 05:19 PM | Harper Molly | Director | Dec 15 '23 | Option Exercise | 5.78 | 10,000 | 57,800 | 10,000 | Dec 19 05:00 PM | Harper Molly | Director | Dec 15 '23 | Sale | 14.39 | 14,000 | 201,420 | 0 | Dec 19 05:00 PM | Tierney David S | Director | Dec 12 '23 | Option Exercise | 1.13 | 50,000 | 56,500 | 383,541 | Dec 14 05:00 PM | Tierney David S | Director | Dec 12 '23 | Sale | 13.32 | 50,000 | 666,250 | 333,541 | Dec 14 05:00 PM | Miller Steve | Chief Op. & Scientific Officer | Dec 11 '23 | Option Exercise | 1.13 | 150,000 | 169,500 | 797,457 | Dec 13 05:00 PM | GRANDE ALICIA | VP, Treasurer and CFO | Dec 11 '23 | Option Exercise | 1.13 | 60,000 | 67,800 | 110,557 | Dec 12 05:00 PM | GRANDE ALICIA | VP, Treasurer and CFO | Dec 11 '23 | Sale | 13.76 | 60,000 | 825,780 | 50,557 | Dec 12 05:00 PM | GRANDE ALICIA | VP, Treasurer and CFO | Dec 08 '23 | Option Exercise | 1.13 | 40,000 | 45,200 | 90,557 | Dec 12 05:00 PM | GRANDE ALICIA | VP, Treasurer and CFO | Dec 08 '23 | Sale | 14.28 | 40,000 | 571,000 | 50,557 | Dec 12 05:00 PM | Daly Richard J | Director | Dec 07 '23 | Option Exercise | 1.13 | 60,000 | 67,800 | 208,000 | Dec 11 05:00 PM | INGENITO GARY | Chief Med. & Reg. Officer | Dec 06 '23 | Option Exercise | 1.13 | 50,000 | 56,500 | 88,367 | Dec 08 05:00 PM | INGENITO GARY | Chief Med. & Reg. Officer | Dec 06 '23 | Sale | 14.02 | 50,000 | 701,000 | 38,367 | Dec 08 05:00 PM | Miller Steve | Chief Op. & Scientific Officer | Dec 05 '23 | Sale | 14.24 | 40,000 | 569,600 | 647,457 | Dec 07 05:00 PM | DENKHAUS DONALD A | Director | Aug 03 '23 | Option Exercise | 1.13 | 60,000 | 67,800 | 393,000 | Aug 04 05:00 PM | MCENANY PATRICK J | President and CEO | May 16 '23 | Option Exercise | 0.79 | 173,849 | 137,341 | 4,119,285 | May 17 05:04 PM | MCENANY PATRICK J | President and CEO | May 15 '23 | Option Exercise | 0.79 | 26,151 | 20,659 | 3,971,587 | May 17 05:04 PM | MCENANY PATRICK J | President and CEO | May 15 '23 | Sale | 13.23 | 26,151 | 345,978 | 3,945,436 | May 17 05:04 PM | Daly Richard J | Director | May 12 '23 | Option Exercise | 0.79 | 50,000 | 39,500 | 148,000 | May 16 05:01 PM | Miller Steve | Chief Operating Officer | May 11 '23 | Option Exercise | 0.79 | 100,000 | 79,000 | 687,457 | May 12 05:00 PM | Tierney David S | Director | May 11 '23 | Option Exercise | 0.79 | 20,000 | 15,800 | 333,541 | May 12 05:01 PM | COELHO PHILIP H | Director | May 04 '23 | Option Exercise | 0.79 | 50,000 | 39,500 | 204,887 | May 05 05:00 PM |
|